|
Smith, D C; Redman, B G; Flaherty, L E et al. (1998) A phase II trial of oral diethylstilbesterol as a second-line hormonal agent in advanced prostate cancer. Urology 52:257-60
|
|
Lehr, J E; Pienta, K J (1998) Preferential adhesion of prostate cancer cells to a human bone marrow endothelial cell line. J Natl Cancer Inst 90:118-23
|
|
Pilat, M J; Schwab, E D; Yao, K L et al. (1998) Examination of the DNA methylation properties in nontumorigenic and tumorigenic breast epithelial cell lines. Anticancer Res 18:2575-82
|
|
Pilat, M J; Lehr, J E; Quigley, M M et al. (1998) The effect of amiloride on the metastatic properties of prostate cancer in the Dunning rat model. Oncol Rep 5:889-92
|
|
Lehr, J E; Pienta, K J; Yamazaki, K et al. (1998) A model to study c-myc and v-H-ras induced prostate cancer progression in the Copenhagen rat. Cell Mol Biol (Noisy-le-grand) 44:949-59
|
|
Smith, D C; Dunn, R L; Strawderman, M S et al. (1998) Change in serum prostate-specific antigen as a marker of response to cytotoxic therapy for hormone-refractory prostate cancer. J Clin Oncol 16:1835-43
|
|
Pienta, K J; Redman, B G; Bandekar, R et al. (1997) A phase II trial of oral estramustine and oral etoposide in hormone refractory prostate cancer. Urology 50:401-6; discussion 406-7
|
|
Replogle-Schwab, T S; Schwab, E D; Pienta, K J (1997) Development of doxorubicin resistant rat prostate cancer cell lines. Anticancer Res 17:4535-8
|
|
Yee, C S; Schwab, E D; Lehr, J E et al. (1997) The effect of castanospermine on the metastatic properties of prostate cancer cells. Anticancer Res 17:3659-63
|
|
Smith, D C; Pienta, K J (1997) The use of prostate-specific antigen as a surrogate end point in the treatment of patients with hormone refractory prostate cancer. Urol Clin North Am 24:433-7
|
Showing the most recent 10 out of 35 publications
